Downregulate the NF-κB signaling pathway mediated by JNK/p38 MAPK, reduce the expression of inflammatory cytokines induced by BLM, inhibit macrophage activation, ameliorate lung inflammation, and alleviate pulmonary fibrosis. This evidence concerns the gene NFKB1 and pulmonary fibrosis.